The fetal liver is a major hematopoietic site containing progenitor cells that give rise to nearly all blood cells, including B-1 cells. Because the fetal liver is not a de novo site of hematopoietic stem cell (HSC) or progenitor-cell emergence, it must be seeded by yolk sac (YS)-derived erythromyeloid progenitors at embryonic day (E) 8.5-E10 and aorta-gonado-mesonephros (AGM)-derived HSCs at E10.5-E11. 5 . Although the B-1 progenitor cell pool in the fetal liver is considered to be of HSC origin, we have previously proposed that YS-derived B-1 progenitors may also contribute to this pool. Until now, it has been impossible to determine whether HSCindependent B-1 progenitor cells exist in the fetal liver. Here, we demonstrate the presence of transplantable fetal-liver B-1 and marginal zone B progenitor cells in genetically engineered HSCdeficient embryos. HSC-deficient YS and AGM tissues produce B-1 progenitors in vitro and thus may serve as sites of origin for the B-1 progenitors that seed the fetal liver. Furthermore, we have found that core-binding factor beta (Cbfβ) expression is required for fetal-liver B-1 progenitor cell maturation and expansion. Our data provide, to our knowledge, the first evidence for the presence of B-1 progenitor cells in the fetal liver that arise independently of HSCs and implicate Cbfβ as a critical molecule in the development of this lineage.
TEK | hemogenic endothelial cell | immune layered model T he immune layered model proposed by Herzenberg and Herzenberg in 1989 (1) predicted B-1 and B-2 lineage production through three waves of B lymphopoiesis arising from different precursors during development (2) : According to this model, the first wave gives rise exclusively to innate immune B cells in early embryonic life and may be derived from progenitor cells independent of hematopoietic stem cells (HSCs), challenging the stem-cell theory that all blood cells are products of HSCs. The second and third waves are comprised of HSCs and HSC-derived progenitors in the fetal liver, neonatal bone marrow (BM) (the second wave), and adult BM (the third wave), respectively. Importantly, AA4.1
lo-neg B-1 specific progenitors have been identified in the second wave (3) . The second wave produces more B-1 cells than B-2 cells whereas the third wave displays an opposite skewing of B-cell differentiation (4) (5) (6) (7) . In fact, the B-1 cell-producing abilities of HSCs and common lymphoid progenitor cells decline with advancing age (6) , and, in particular, CD5
+ B-1a cells are not produced by adult HSCs when examined by single HSC transplantation assay (7) . Although the second and third waves have been examined in detail, it is unclear whether the first wave exists and contributes to innate immunity in postnatal life and whether the B-1 progenitor cells in wave 2 in the fetal liver are all HSC-derived or contain derivatives of the wave 1 HSC-independent embryonic progenitor cells. , residing in the peritoneal and pleural cavities. These cells produce stereotypic natural antibodies in a T cellindependent manner and execute important roles in the first line of defense against microbial infection (8, 9) . B-1 cells are segregated into CD5
+ B-1a and CD5 − B-1b cells. Marginal zone (MZ) B cells, named after the restricted localization of these cells in the splenic marginal zone, are usually categorized as BM HSCderived B-2 cells but share similar functions with B-1 cells, such as rapid production of IgM antibodies against bacterial pathogens in a T cell-independent manner. There is evidence that a portion of MZ B cells is also of embryonic or fetal origin (10) (11) (12) .
We have recently reported that yolk sac (YS) and para-aorticsplanchnopleura (P-Sp) hemogenic endothelial cells (HECs) harvested before the first emergence of HSC give rise to transplantable, functional B-1a, B-1b, and MZ B cells in vitro and thus have provided supportive evidence for the first wave of B cells (13) . However, because we isolated and cultured YS/P-Sp cells in vitro to allow them to differentiate into B-1 progenitor cells, whether YS/P-Sp-derived B progenitor cells seed the fetal liver in vivo and contribute to the B-1 progenitor cell pool or mature B-1 or MZ B cells in postnatal life has never been established. In other words, to address the question whether the first wave of B lymphopoiesis is present in vivo or not, we have to confirm the existence of HSC-independent B-1 progenitor cells in the fetal liver.
The fetal liver is an organ dependent upon hematopoietic stem/progenitor cell seeding from different hematopoietic tissues.
Significance
All lymphoid cells are considered to be products of hematopoietic stem cells (HSCs); however, it has been suggested, but not proven, that innate immune B-1 progenitor cells develop independently of HSCs in the fetal liver. B-1 cells, especially B-1a cells, are not replaced by adult bone marrow transplantation. Thus, it is critical to understand the origin and mechanisms required to sustain these cells in vivo because B-1 cells play important roles in the first line of defense against microbial infection and in preventing organ damage in autoimmune patients and infections in some patients after bonemarrow transplantation. We demonstrate that B-1 progenitor cells can develop independently of HSCs in the fetal liver and that their development relies critically on the expression of core-binding factor beta.
It is an established concept that erythro-myeloid progenitors (EMPs) derived from embryonic day (E) 8.5-E10 YSs seed the fetal liver to support homeostatic hematopoiesis in the embryo whereas HSCs that emerge in the aorta-gonado-mesonephros (AGM) region seed the fetal liver at E11 and provide hematopoietic support later in development (14, 15) . However, it is unknown whether the YS/P-Sp HEC-derived B-1 lymphoid progenitors seed the fetal liver. Because the B-1 progenitor cell pool in the fetal liver is considered to be an HSC derivative and because HSCs exist in the fetal liver concomitant with B-1 progenitor cells, it has been impossible to prove the existence of HSC-independent B lymphopoiesis in the fetal liver. To specifically address this question, we have used a unique mouse model devoid of HSC but known to possess some uncharacterized fetalliver B cells (16, 17) .
Core-binding factor beta (CBFβ) is the common non-DNAbinding subunit of the Cbf family of heterodimeric transcription factors. By associating with CBFα subunits, CBFβ increases the affinity of CBFα DNA-binding. Runt related transcription factor 1 (Runx1) also called core-binding factor alpha 2 (Cbfα2) −/− embryos die at E12 and display severe deficiencies in definitive EMP, lymphoid cells, and HSCs (18) . CBFβ is required for Runx1 function, and loss of CBFβ in embryos leads to embryonic lethality at E11-E13 similar to Runx1 −/− embryos with a severe defect in definitive hematopoiesis and HSCs (17, 19) . However, when Cbfβ expression was restored in Cbfβ −/− embryos under transgenic control of the endothelial promoter endothelial-specific receptor tyrosine kinase (Tek) (Cbfβ −/− :Tek-GFP/Cbfβ), EMP formation and rare B and T cells were observed (16) . In these rescued embryos, lymphoid progenitors (Lin
were detectable in the E14 fetal liver and produced B or T cells in OP9 or OP9-DL1 in vitro cocultures, respectively. However, E14 Cbfβ −/− :Tek-GFP/ Cbfβ fetal-liver cells failed to reconstitute recipient peripheral blood (PB) and BM upon transplantation, indicating that Cbfβ −/− : Tek-GFP/Cbfβ embryos contain lymphoid progenitors without transplantable HSCs. It has been previously reported that lymphoid progenitor cells are present in the YS and P-Sp before HSC emergence at an early stage (E8.25-E9.5) of embryo development (13, (20) (21) (22) (23) . Furthermore, the presence of multipotent progenitor cells with myeloid, B-cell, and T-cell lineage potentials without long-term HSC activity also has been reported (24) (25) (26) . Whether the B and T progenitor cells emerge from a common HEC or are independently generated has not been fully resolved. Nonetheless, the fact that lymphoid progenitor cells are present prior to HSC emergence suggests that the initial phases of developmental hematopoiesis may not follow the same paradigm as adult BM HSC development where all of the lymphoid progenitor cells are HSC-derived (15, 27) . Indeed, transplantable HSCs were rescued when Cbfβ was expressed under transgenic control of the Ly6a promoter in the Cbfβ −/− embryos (Cbfβ −/− : Ly6a-GFP/Cbfβ), suggesting that Cbfβ is required in the Ly6a + HECs for producing transplantable HSCs that repopulate myeloid and lymphoid lineages (16) . Based on these findings and our previous reports that B-1 (but not B-2) and T lymphoid progenitor cells are present in the embryo before HSC emergence (13, 20) , we hypothesized that the unspecified B cells detected in the Cbfβ −/− : Tek-GFP/Cbfβ embryos that do not harbor transplantable HSCs are HSC-independent B-1 progenitor cells that constitute the first wave of B lymphopoiesis.
In the present study, we confirm the existence of fetal-liver AA4. 
CD19
+ B220 lo-neg B-1 progenitor cells were also detected in the fetal spleen from E15.5 until birth ( Fig. 1 G-J and N) . Few AA4.1
+ B cells were detected in the fetal liver and spleen of Cbfβ −/− :Tek-GFP/Cbfβ embryos whereas WT fetal liver contained more AA4.1
+ B cells than B-1 progenitor cells (Fig. 1 A, E 
CD43
+ cells are known to give rise mainly to B-1 cells upon transplantation (3, 5) . Thus, the fetal-liver AA4.1 +
CD19
+ B220 + population contains more B-1 lineage than B-2 lineage cells and is considered to be differentiated from both HSCs (through AA4.1
+ phenotype) and B-1 progenitor cells as we have previously reported (13) . Therefore, severe reduction of AA4.1 + CD19
+ B220 + cells in the fetal liver ( Fig. 1 E and F) and spleen ( (Fig. 1N ). This result suggests that at least 40% of B-1 progenitor cells in the fetal-neonatal spleen are HSC-independent, a point that contrasts with the common perception that all lymphoid cells are HSC-derived. 
B-1 Progenitors in Cbfβ

B220
+ B cells but at a lower frequency compared with WT YS/AGM (Fig. 2B) . These cultured YS/P-Sp/AGM-derived AA4.1
+ B progenitor cells were confirmed to become mature B-1 cells in vivo upon transplantation as previously reported (13) . Although there is a study suggesting that placenta has the potential of producing B cells at a pre-HSC stage (29), we found maternal B cells in the placenta at this time point whereas YS and P-Sp derived B-1 cells were confirmed to be embryonic in origin (13) . Thus, although we cannot exclude the possibility of the placenta as a production site for the first wave (Fig. 1N) , and mice died 1 d after birth as previously reported (16) . Because mature B-1 cells are not detectable in the peritoneal cavity until 5 d after birth (30), we were unable to find mature peritoneal B-1 cells in the Cbfβ −/− (NSG) neonates. Although WT fetal-liver MNCs displayed multilineage repopulation in the PB of the recipient mice (Fig. 3A, Upper) , no apparent engraftment was found in the PB of the recipient mice transplanted with Cbfβ −/− : Tek-GFP/Cbfβ fetal-liver MNCs as previously reported (16) (Fig.  3A, Lower) . However, in the host peritoneal cavity and spleen, B-1 and MZ B cells were reconstituted from donor Cbfβ −/− :Tek-GFP/Cbfβ fetal-liver MNCs (Fig. 3B) . No donor-derived B-2 cells or T cells were detected (Figs. 3B and 4E ). These data indicated that HSC-deficient fetal-liver MNCs contain progenitor cells that can mature into only B-1 and MZ B cells in vivo upon transplantation.
CBFβ Is Required for Maturation and Expansion of B-1 and MZ B Cells.
Although transplantable B-1 and MZ B-cell progenitors are present in HSC-deficient fetal liver, the level of chimerism was significantly lower than donor contributions from WT embryos (WT 97.8 ± 1.3% vs. Cbfβ −/− :Tek-GFP/Cbfβ 1.98 ± 0.3% in the peritoneal cavity and WT 92.8 ± 3.3% vs. Cbfβ −/− :Tek-GFP/Cbfβ 3.4 ± 2.4% in the spleen). It has been reported that Cbfβ is required in all blood-lineage cells for their development, but TEK-GFP/Cbfβ expression was not sustained once Tek-GFP/Cbfβ + HECs become hematopoietic cells (16, 17) . We confirmed that WT fetal-liver B-1 progenitor cells express Cbfβ at a similar level to HSCs (Fig. 4A) . However, B-1 progenitor cells from Cbfβ −/− : Tek-GFP/Cbfβ do not express TEK-GFP/Cbfβ (Fig. 4B) , thus having lost Cbfβ expression during differentiation from TEK + HEC to B-1 progenitor cells (Fig. 4C) . We have also recently determined that loss of Runx1 or Cbfβ in the B-cell lineage caused B-2 cell maturation defects (31) . In this mouse model of Cbfβ deficient in B-cell lineage, we also observed a threefold reduction in B-1 cell number compared with WT mice, indicating that Cbfβ plays a critical role in B-1 cell development (Fig. S1 ) (31) . Thus, we hypothesized that Cbfβ −/− :Tek-GFP/Cbfβ fetalliver B-1 progenitor cells would require ongoing Cbfβ expression to mature into functional B-1 cells. To test the hypothesis, we overexpressed Cbfβ in Cbfβ −/− :Tek-GFP/Cbfβ fetal-liver MNCs using a retrovirus vector that constitutively produced CBFβ (Fig.  4D and Fig. S2A ). Once retrovirally infected fetal-liver Cbfβ −/− : Tek-GFP/Cbfβ MNCs were transplanted into irradiated NSG neonates, Cbfβ −/− :Tek-GFP/Cbfβ-derived cells displayed dramatically improved engraftment capacity in up to 49% of donor cells in the peritoneal cavity (Fig. 4E) and improved maturation into IgM + cells in the spleen (Fig. S3) , and displayed only B-1 cell reconstitution in the peritoneal cavity and MZ and B-1 cells in the spleen 12 wk after transplantation (Fig. 4 E and F and Fig. S3 ). Nearly all (98%) of these Cbfβ −/− :Tek-GFP/Cbfβ-derived cells expressed retroviral Cbfβ-GFP (Fig. S2B ) and displayed 15-25 times more Cbfβ mRNA expression compared with WT peritoneal B-1 cells (Fig. S2C) . In contrast, Cbfβ −/− :Tek-GFP/Cbfβ fetal-liver cells infected with the empty vector control virus poorly engrafted (Fig. 4E, Middle) . These results indicate that Cbfβ overexpression rescues maturation and expansion of impaired B-1 progenitor cells from Cbfβ −/− :Tek-GFP/Cbfβ embryos. Furthermore, Cbfβ expressing engrafted B-1 cells in the recipient mice were functional, displaying T cell-independent antiphosphorylcholine IgM secretion detected by enzyme-linked immunospot (Elispot) assay (Fig. 4 G and H) . Taken 
Discussion
In the current study, using unique HSC-deficient embryos, we have for the first time, to our knowledge, proven that progenitor cells that give rise to only B-1 and MZ cells exist in the fetal liver in the absence of HSCs. Although we were not able to quantitatively estimate the percentage contribution of the first wave of B cells in postnatal life (because the Cbfβ −/− :Tek-GFP/Cbfβ neonates die just after birth), it is probable that at least 40% of neonatal spleen B cells are derived from HSC-independent progenitors. Since fetal-liver cells do not produce any blood cells de novo but rely upon seeding from other sites, these B-1 progenitor cells must have been seeded from another site(s) of embryonic hematopoiesis, such as the yolk sac or embryo proper.
We Another important finding from our current work is that Cbfβ expression is required for B-1 cell development as well as B-2 cell development as previously reported (31) . However, B-1 cell maturation is permissive in Cbfβ (35, 36) , prevention of atherosclerosis (37) , and prevention of infections in blood stem cell transplanted patients (38) .
Materials and Methods
Mice. Cbfβ and 10 ng/mL Flit3-ligand (PEPROTECH) as previously reported (13) . Floating cells in the culture medium were collected at optimal time points, and we analyzed their surface markers by flow cytometry. CD5 (53-7.3), CD3e (145-2C11), Ter119 (TER-119), c-kit (2B8), Sca-1 (D7), and IL7Ra (A7R34) (all purchased from eBioscience). A lineage mixture containing anti-Ter119, CD11b, and CD3 was used for lineage negative gating. Cells were analyzed on LSRII or sorted on FACS Aria (Becton Dickinson). lo-neg B-1 progenitors were sorted, and RNA was extracted using RNasy (QIAGEN) following the manufacturer's instructions. cDNA was made using Super Scrip III fast strand Synthesis System (Invitrogen). Real-time PCR was performed using FastStart Universal SYBR Green Master (Rox) (Roche) by 7500 RealTime PCR System (Life Technologies). The following sets of primers were used: Cbfβ, forward, GCAAGTTCGAGAACGAGGAG; reverse, CCCGTGTACT-TAATCTCGCA; β-actin, forward, TCCTGTGGCATCCATGAAACT; reverse, GAAG-CACTTGCGGTGCACGAT.
Expression Vectors and Retrovirus Production. Full-length cDNA of mouse Cbfβ was purchased from TrueClone (catalog no. MC204426) and amplified by PCR. cDNA of mouse Cbfβ was inserted into an MSCV-IRES-GFP (MIG) plasmid. Retroviruses carrying empty vector (MIG-empty) or MIG-Cbfβ were produced using the Phoenix cell line. Virus supernatants were concentrated by centrifuging at 19,000 × g, 4°C for 100 min. WT and Cbfβ −/− : Tek-GFP/ Cbfβ fetal-liver MNCs were plated on retronectin-coated 24-well plates in induction medium with 10 ng/mL stem cell factor, 10 ng/mL IL-7, and 10 ng/mL Flit3-ligand. Concentrated virus supernatant was added into each well, and spin infection was performed by centrifuging at 1,000 × g, 32°C for 100 min.
The next morning, the medium was half changed, and second-spin infection was done. Three hours after second infection, cells were harvested and used for the transplantation assay. Infectious efficiency was confirmed by detecting GFP + cells by flow cytometry.
Elispot. Elispot was done as previously described (39) . Donor-derived B-1 or B-2 cells in the peritoneal cavity of recipient mice were sorted on a FACS Aria (Becton Dickinson), suspended in Elispot medium (RPMI 1640 medium with 10% FBS and 5 × 10 −5 M β-mercaptoethanol), supplemented with 10 ng/mL IL-5, and cultured for 36-48 h in 96-well plates precoated with phosphorylcholine-conjugated keyhole limpet hemocyanin. Five hundred to 1,000 cells were distributed into an Elispot MultiScreen HTS Filter Plate (Millipore) precoated with anti-mouse IgM and cultured in Elispot medium overnight. After washing, alkaline phosphatase-conjugated goat anti-mouse IgM (Southern Biotech) was applied to each well and incubated for 45 min. After washing, spots were visualized using BCIP/NBTplus substrate as described (Mabtech).
Statistics. All experiments were completed in triplicate. The Student t test was used for statistical analysis.
